1. Executive Summary

2. Global Total Market Value of the Top 20 Vaccine Companies (2015 - 2019)

3. Market Share Analysis of the Top 20 Vaccine Companies (%)

4. Key Market Drivers and Inhibitors in the Vaccine Market
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. Major Deals and Agreement Happenings in the Vaccine Market
5.1 Merger & Acquisitions
5.2 Collaboration Deals
5.3 Licensing Agreement
5.4 Exclusive Agreement
5.5 Distribution Agreement
5.6 Partnership Deals

6. Top 20 Vaccine Companies in the Vaccine Market
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Vaccines Portfolio
6.1.3 Vaccines Market Value Analysis
6.1.4 Promising Vaccines in the Clinical Development
6.1.5 Recent Development
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Vaccines Portfolio
6.2.3 Vaccines Market Value Analysis
6.2.4 Promising Vaccines in the Clinical Development
6.2.5 Recent Development
6.3 Merck & Co., Inc.
6.3.1 Business Overview
6.3.2 Vaccines Portfolio
6.3.3 Vaccines Market Value Analysis
6.3.4 Promising Vaccines in the Clinical Development
6.3.5 Recent Development
6.4 Pfizer
6.4.1 Business Overview
6.4.2 Vaccines Portfolio
6.4.3 Vaccines Market Value Analysis
6.4.4 Promising Vaccines in the Clinical Development
6.4.5 Recent Development
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Vaccines Portfolio
6.5.3 Vaccines Market Value Analysis
6.5.4 Recent Development
6.6 Mitsubishi Tanabe Pharma
6.6.1 Business Overview
6.6.2 Vaccines Portfolio
6.6.3 Vaccines Market Value Analysis
6.6.4 Promising Vaccines in the Clinical Development
6.6.5 Recent Development
6.7 Emergent BioSolutions
6.7.1 Business Overview
6.7.2 Vaccines Portfolio
6.7.3 Vaccines Market Value Analysis
6.7.4 Promising Vaccines in the Clinical Development
6.7.5 Recent Development
6.8 Astlellas Pharma Inc
6.8.1 Business Overview
6.8.2 Vaccines Portfolio
6.8.3 Vaccines Market Value Analysis
6.8.4 Recent Development
6.9 Valneva
6.9.1 Business Overview
6.9.2 Vaccines Portfolio
6.9.3 Vaccines Market Value Analysis
6.9.4 Promising Vaccines in the Clinical Development
6.9.5 Recent Development
6.10 Seqirus (CSL Limited)
6.10.1 Business Overview
6.10.2 Vaccines Portfolio
6.10.3 Vaccines Market Value Analysis
6.10.4 Promising Vaccines in the Clinical Development
6.10.5 Recent Development
6.11 Bavarian Nordic
6.11.1 Business Overview
6.11.2 Vaccines Portfolio
6.11.3 Vaccines Market Value Analysis
6.11.4 Promising Vaccines in the Clinical Development
6.11.5 Recent Development
6.12 Sinovac
6.12.1 Business Overview
6.12.2 Vaccines Portfolio
6.12.3 Vaccines Market Value Analysis
6.12.4 Promising Vaccines in the Clinical Development
6.12.5 Recent Development
6.13 Panacea Biotec
6.13.1 Business Overview
6.13.2 Vaccines Portfolio
6.13.3 Vaccines Market Value Analysis
6.13.4 Promising Vaccines in the Clinical Development
6.13.5 Recent Development
6.14 Dynavax Technologies Corporation
6.14.1 Business Overview
6.14.2 Vaccines Portfolio
6.14.3 Vaccines Market Value Analysis
6.14.4 Promising Vaccines in the Clinical Development
6.14.5 Recent Development
6.15 Bharat Biotech
6.15.1 Business Overview
6.15.2 Vaccines Portfolio
6.15.3 Promising Vaccines in the Clinical Development
6.15.4 Recent Development
6.16 Serum Institute of India
6.16.1 Business Overview
6.16.2 Vaccines Portfolio
6.16.3 Promising Vaccines in Clinical Development
6.16.4 Recent Development
6.17 Biological E. Limited
6.17.1 Business Overview
6.17.2 Vaccines Portfolio
6.17.3 Promising Vaccines in the Clinical Development
6.17.4 Recent Development
6.18 Grifols
6.18.1 Business Overview
6.18.2 Vaccines Portfolio
6.18.3 Recent Development
6.19 Hualan Biological Engineering Inc
6.19.1 Business Overview
6.19.2 Influenza Vaccines Portfolio
6.19.3 Recent Development
6.20 Gamma Vaccines Pty Ltd
6.20.1 Business Overview
6.20.2 Influenza Vaccines Portfolio
6.20.3 Recent Development